The Ras-Membrane Interface: Isoform-specific Differences in The Catalytic Domain
- PMID: 25566993
- DOI: 10.1158/1541-7786.MCR-14-0535
The Ras-Membrane Interface: Isoform-specific Differences in The Catalytic Domain
Abstract
The small GTPase Ras is mutated in about 20% of human cancers, primarily at active site amino acid residues G12, G13, and Q61. Thus, structural biology research has focused on the active site, impairment of GTP hydrolysis by oncogenic mutants, and characterization of protein-protein interactions in the effector lobe half of the protein. The C-terminal hypervariable region has increasingly gained attention due to its importance in H-Ras, N-Ras, and K-Ras differences in membrane association. A high-resolution molecular view of the Ras-membrane interaction involving the allosteric lobe of the catalytic domain has lagged behind, although evidence suggests that it contributes to isoform specificity. The allosteric lobe has recently gained interest for harboring potential sites for more selective targeting of this elusive "undruggable" protein. The present review reveals critical insight that isoform-specific differences appear prominently at these potentially targetable sites and integrates these differences with knowledge of Ras plasma membrane localization, with the intent to better understand the structure-function relationships needed to design isoform-specific Ras inhibitors.
©2015 American Association for Cancer Research.
Similar articles
-
DRoP: a water analysis program identifies Ras-GTP-specific pathway of communication between membrane-interacting regions and the active site.J Mol Biol. 2014 Feb 6;426(3):611-29. doi: 10.1016/j.jmb.2013.10.036. Epub 2013 Nov 2. J Mol Biol. 2014. PMID: 24189050
-
Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers.Biochem J. 2016 Jun 15;473(12):1719-32. doi: 10.1042/BCJ20160031. Epub 2016 Apr 7. Biochem J. 2016. PMID: 27057007 Free PMC article.
-
Allosteric modulation of Ras positions Q61 for a direct role in catalysis.Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):4931-6. doi: 10.1073/pnas.0912226107. Epub 2010 Mar 1. Proc Natl Acad Sci U S A. 2010. PMID: 20194776 Free PMC article.
-
The role of palmitoylation in regulating Ras localization and function.Biochem Soc Trans. 2013 Feb 1;41(1):79-83. doi: 10.1042/BST20120268. Biochem Soc Trans. 2013. PMID: 23356262 Review.
-
Influence of isoform-specific Ras lipidation motifs on protein partitioning and dynamics in model membrane systems of various complexity.Biol Chem. 2017 May 1;398(5-6):547-563. doi: 10.1515/hsz-2016-0289. Biol Chem. 2017. PMID: 27977396 Review.
Cited by
-
Therapeutic targeting of RAS: New hope for drugging the "undruggable".Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118570. doi: 10.1016/j.bbamcr.2019.118570. Epub 2019 Oct 31. Biochim Biophys Acta Mol Cell Res. 2020. PMID: 31678118 Free PMC article. Review.
-
Oncogenic Ras Isoforms Signaling Specificity at the Membrane.Cancer Res. 2018 Feb 1;78(3):593-602. doi: 10.1158/0008-5472.CAN-17-2727. Epub 2017 Dec 22. Cancer Res. 2018. PMID: 29273632 Free PMC article. Review.
-
KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent Manner.Biophys J. 2019 Mar 19;116(6):1049-1063. doi: 10.1016/j.bpj.2019.02.004. Epub 2019 Feb 15. Biophys J. 2019. PMID: 30846362 Free PMC article.
-
Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers.Int J Mol Sci. 2019 Dec 24;21(1):141. doi: 10.3390/ijms21010141. Int J Mol Sci. 2019. PMID: 31878223 Free PMC article. Review.
-
Discovery of a Bicyclic Peptidyl Pan-Ras Inhibitor.J Med Chem. 2021 Sep 9;64(17):13038-13053. doi: 10.1021/acs.jmedchem.1c01130. Epub 2021 Aug 20. J Med Chem. 2021. PMID: 34415745 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
